AIkido Pharma logo
AIkido Pharma AIKI
report update icon

Annual report 2025
added 03-31-2026

AIkido Pharma Total Current Liabilities | AIKI

Annual Total Current Liabilities AIkido Pharma

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - 1.61 M 1.79 M 1.06 M 877 K 750 K 1.15 M 2.58 M 2.67 M 4.46 M 1.23 M 1.5 M 731 K 893 K

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
4.46 M 731 K 1.64 M

Total Current Liabilities of other stocks in the Biotechnology industry

Issuer Total Current Liabilities Price % 24h Market Cap Country
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
6.4 M - 1.35 % $ 17.8 M chinaChina
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
78.6 M - - $ 2.02 B usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
3.56 M - -10.17 % $ 12.2 K usaUSA
I-Mab I-Mab
IMAB
412 M - - $ 866 M chinaChina
Corner Growth Acquisition Corp. Corner Growth Acquisition Corp.
COOL
30.2 K - -0.89 % $ 114 M usaUSA
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
100 M - - $ 2.18 B usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
1.62 B - - $ 40.3 B usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
42 M - - $ 2.17 B usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
1.77 M - -1.52 % $ 24.7 M usaUSA
Athira Pharma Athira Pharma
ATHA
47.5 M - - $ 269 M usaUSA
Galera Therapeutics Galera Therapeutics
GRTX
645 K - -32.59 % $ 7.61 M usaUSA
Geron Corporation Geron Corporation
GERN
112 M $ 1.42 -2.07 % $ 947 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
556 M - - - russiaRussia
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
9.38 M - - $ 231 M usaUSA
Inhibikase Therapeutics Inhibikase Therapeutics
IKT
8.3 M $ 2.33 - $ 229 M usaUSA
AnPac Bio-Medical Science Co., Ltd. AnPac Bio-Medical Science Co., Ltd.
ANPC
42.3 M - -1.58 % $ 28.1 M chinaChina
Berkeley Lights Berkeley Lights
BLI
45.5 M - -7.31 % $ 87 M usaUSA
Generation Bio Co. Generation Bio Co.
GBIO
35.1 M - - $ 344 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
39.8 M - - $ 3.67 B usaUSA
Akouos Akouos
AKUS
16.8 M - 0.23 % $ 488 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
7.54 M - - $ 7.46 M israelIsrael
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
1.33 M - -4.36 % $ 27 M usaUSA
Freeline Therapeutics Holdings plc Freeline Therapeutics Holdings plc
FRLN
31 M - - $ 384 M britainBritain
Gracell Biotechnologies Gracell Biotechnologies
GRCL
221 M - - $ 3.37 B chinaChina
Jaguar Health Jaguar Health
JAGX
40.7 M $ 0.96 -6.48 % $ 2.24 M usaUSA
Johnson & Johnson Johnson & Johnson
JNJ
54.1 B $ 263.4 1.58 % $ 634 B usaUSA
Advaxis Advaxis
ADXS
25 M - -9.65 % $ 45.9 M usaUSA
Alkermes plc Alkermes plc
ALKS
543 M $ 52.89 -0.15 % $ 8.71 B irlandaIrlanda
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
58.7 M - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
25.2 M - - $ 26.5 M usaUSA
Achieve Life Sciences Achieve Life Sciences
ACHV
9.08 M $ 6.1 -1.13 % $ 266 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
9.31 M - -45.71 % $ 1.2 M canadaCanada
Aptinyx Aptinyx
APTX
6.29 M - -39.0 % $ 4.57 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
45.3 M - -0.23 % $ 916 M usaUSA
AlloVir AlloVir
ALVR
9.71 M - 4.14 % $ 49.1 M usaUSA